Venatorx Pharmaceuticals, based in Malvern, PA, is a research-driven biotechnology company specializing in the development of innovative antibiotics to combat serious infections. The company boasts a robust pipeline of promising treatments, including Cefepime-Taniborbactam, Ceftibuten-Ledaborbactam, and Etzadroxil PBP Inhibitor. Through a commitment to scientific excellence, Venatorx Pharmaceuticals has garnered recognition for its groundbreaking work in the field of infectious disease therapeutics. The company's dedication to addressing unmet medical needs is evident in its portfolio of publications, manuscripts, and conference presentations. Generated from the website content